Valuation: Merck & Co., Inc.

Capitalization 296B 249B 228B 217B 403B 26,813B 417B 2,644B 1,051B 12,918B 1,110B 1,087B 45,114B P/E ratio 2025
14.5x
P/E ratio 2026 * 27.6x
Enterprise value 320B 270B 246B 235B 437B 29,019B 452B 2,861B 1,138B 13,980B 1,201B 1,177B 48,825B EV / Sales 2025
4.02x
EV / Sales 2026 * 4.85x
Free-Float
70.67%
Yield 2025 *
2.71%
Yield 2026 * 2.82%
1 day+2.07%
1 week+0.04%
Current month+10.62%
1 month+12.67%
3 months+31.26%
6 months+47.48%
Current year+15.88%
1 week 116.1
Extreme 116.1
123.33
1 month 106.03
Extreme 106.03
123.33
Current year 104.43
Extreme 104.43
123.33
1 year 73.31
Extreme 73.31
123.33
3 years 73.31
Extreme 73.31
134.63
5 years 70.89
Extreme 70.89
134.63
10 years 49.24
Extreme 49.24
134.63
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2021
Director of Finance/CFO 57 01/04/2021
Chief Tech/Sci/R&D Officer 57 01/08/2020
Director TitleAgeSince
Director/Board Member 65 27/11/2007
Director/Board Member 73 01/09/1995
Chairman 59 01/12/2022
Change 5d. change 1-year change 3-years change Capi.($)
+2.06%+0.04%+44.49%+11.35% 296B
+1.96%-0.37%+20.92%+200.88% 930B
-0.39%+1.31%+54.62%+49.39% 589B
+1.69%+3.54%+19.58%+50.48% 402B
+0.15%+0.90%+20.75%+28.80% 374B
+1.58%+6.79%+25.89%+31.87% 315B
+0.83%+3.90%+27.47%+54.99% 307B
+1.74%+5.57%-44.89%-37.23% 216B
+1.17%-4.41%+23.71%+50.78% 197B
+2.19%+1.79%+46.50%+77.43% 188B
Average +1.28%+3.02%+23.91%+51.87% 381.47B
Weighted average by Cap. +1.23%+2.77%+26.41%+77.00%

Financials

2025 2026 *
Net sales 64.78B 54.59B 49.82B 47.55B 88.31B 5,869B 91.33B 579B 230B 2,827B 243B 238B 9,875B 66.71B 56.21B 51.3B 48.97B 90.93B 6,044B 94.04B 596B 237B 2,912B 250B 245B 10,168B
Net income 19.82B 16.7B 15.24B 14.55B 27.01B 1,795B 27.94B 177B 70.39B 865B 74.31B 72.79B 3,021B 10.64B 8.97B 8.19B 7.81B 14.51B 964B 15.01B 95.08B 37.81B 465B 39.92B 39.1B 1,622B
Net Debt 24.34B 20.51B 18.72B 17.87B 33.18B 2,205B 34.32B 217B 86.47B 1,062B 91.28B 89.41B 3,710B 27.63B 23.29B 21.25B 20.28B 37.67B 2,503B 38.96B 247B 98.16B 1,206B 104B 102B 4,212B
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.4%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (20%); - sale of animal health products (9.2%); - other (1.4%). Net sales are distributed geographically as follows: the United States (50.3%), Europe/Middle East/Africa (21.8%), Latin America (5.4%), China (8.6%), Japan (5.1%), Asia/Pacific (4.8%) and other (4%).
Employees
74,000
Calendar
03-16 -
Date Price Change Volume
13/02/26 121.84 $ +2.18% 1,898,097
12/02/26 119.24 $ -0.06% 13,453,271
11/02/26 119.31 $ +1.84% 10,885,294
10/02/26 117.15 $ -0.42% 11,849,545
09/02/26 117.65 $ -3.51% 16,158,727
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
119.24USD
Average target price
123.54USD
Spread / Average Target
+3.60%

Quarterly revenue - Rate of surprise